Overview
- India remains the leading supplier of vaccines to the WHO by providing 70% of its doses and supplies 14% of generics imported by the US.
- Minister Anupriya Patel highlighted India’s retention of WHO GBT Maturity Level 3 status, reflecting the strength of its regulatory framework.
- Fifteen countries, including recent entrant Cuba, recognize the Indian Pharmacopoeia as an official reference for drug standards.
- Forum discussions centered on harmonizing pharmacopeial standards and strengthening global regulatory collaboration.
- The IPC launched a digital coffee table book tracing its journey as India’s apex drug standards body and showcased Jan Aushadhi Kendras as models for affordable healthcare.